NMD Pharma
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$81.4M
NMD Pharma is a biotech company focused on developing small molecule therapies for neuromuscular diseases by targeting the skeletal muscle chloride ion channel (ClC-1).
Focus Areas
Clinical-stage biotech
Small molecule therapies
Neuromuscular diseases
Skeletal muscle chloride ion channel (ClC-1)
Phase 2 studies
Pipeline expansion
Investors
